Deanna D Strable Soethout Principal Financial Group Inc (PFG) insider trading activity

Deanna D Strable Soethout is President and CEO of PRINCIPAL FINANCIAL GROUP INC. Currently has a direct ownership of 153,468 shares of PFG, which is worth approximately $13 Million. The most recent transaction as insider was on Jun 30, 2023, when has been sold 179 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

0.34% 3M change

36.59% 12M change

Total Value Held $13 Million

DEANNA D STRABLE-SOETHOUT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2023	BUY Grant, award, or other acquisition	-	179 Added 0.21%	84,552 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	181 Added 0.21%	84,373 Common Stock
Feb 27 2023	BUY Grant, award, or other acquisition	-	20,336 Added 17.87%	93,438 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	75 Added 0.1%	72,978 Common Stock
Oct 28 2022	SELL Sale (or disposition) back to the issuer	$903,115 $85.28 p/Share	10,590 Reduced 12.68%	72,903 Common Stock
Oct 28 2022	BUY Grant, award, or other acquisition	$475,279 $44.88 p/Share	10,590 Added 11.26%	83,493 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	87 Added 0.12%	72,903 Common Stock

Aug 10 2022	SELL Sale (or disposition) back to the issuer	$1,217,209 $75.09 p/Share	16,210 Reduced 18.28%	72,475 Common Stock
Aug 10 2022	BUY Grant, award, or other acquisition	$497,647 $30.7 p/Share	16,210 Added 15.45%	88,685 Common Stock
Jun 24 2022	BUY Grant, award, or other acquisition	-	90 Added 0.12%	72,475 Common Stock
Mar 25 2022	BUY Grant, award, or other acquisition	-	148 Added 0.2%	72,385 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	13,897 Added 20.21%	54,860 Common Stock
May 03 2021	SELL Open market or private sale	$1,035,589 $65.07 p/Share	15,915 Reduced 28.1%	40,716 Common Stock
Feb 26 2021	SELL Open market or private sale	$199,796 $57.15 p/Share	3,496 Reduced 5.81%	56,631 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	3,496 Added 5.49%	60,127 Common Stock
Dec 09 2020	SELL Open market or private sale	$977,160 $51.0 p/Share	19,160 Reduced 25.28%	56,631 Common Stock
Mar 03 2020	SELL Open market or private sale	$380,732 $46.06 p/Share	8,266 Reduced 9.89%	75,343 Common Stock
Feb 24 2020	BUY Grant, award, or other acquisition	-	8,266 Added 9.0%	83,609 Common Stock
Feb 25 2019	BUY Grant, award, or other acquisition	-	13,890 Added 15.67%	74,779 Common Stock
Feb 26 2018	BUY Grant, award, or other acquisition	-	6,604 Added 9.84%	60,534 Common Stock
Feb 07 2018	SELL Bona fide gift	-	280 Reduced 0.52%	53,930 Common Stock
Nov 28 2017	SELL Open market or private sale	$1,324,673 $70.07 p/Share	18,905 Reduced 25.86%	54,210 Common Stock
Nov 28 2017	BUY Exercise of conversion of derivative security	$419,880 $22.21 p/Share	18,905 Added 20.54%	73,115 Common Stock

Also insider at

ELV

Elevance Health, Inc. Healthcare

Director

DDS